Galectin Therapeutics, Inc. (GALT)
3.29
-0.09
(-2.66%)
USD |
NASDAQ |
Nov 11, 16:00
3.31
+0.02
(+0.61%)
After-Hours: 20:00
Galectin Therapeutics Market Cap : 218.17M for Nov. 11, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 11, 2026 | 218.17M |
| November 10, 2026 | 224.13M |
| November 09, 2026 | 229.44M |
| November 06, 2026 | 208.22M |
| November 05, 2026 | 197.94M |
| November 04, 2026 | 230.10M |
| November 03, 2026 | 222.14M |
| November 02, 2026 | 220.82M |
| October 30, 2026 | 220.16M |
| October 29, 2026 | 233.42M |
| October 28, 2026 | 234.74M |
| October 27, 2026 | 224.13M |
| October 26, 2026 | 211.54M |
| October 23, 2026 | 211.54M |
| October 22, 2026 | 224.13M |
| October 21, 2026 | 223.47M |
| October 20, 2026 | 227.45M |
| October 19, 2026 | 231.76M |
| October 16, 2026 | 240.05M |
| October 15, 2026 | 246.02M |
| October 14, 2026 | 241.38M |
| October 13, 2026 | 244.69M |
| October 12, 2026 | 256.63M |
| October 09, 2026 | 261.27M |
| October 08, 2026 | 241.38M |
| Date | Value |
|---|---|
| October 07, 2026 | 240.05M |
| October 06, 2026 | 249.33M |
| October 05, 2026 | 247.34M |
| October 02, 2026 | 258.62M |
| October 01, 2026 | 249.33M |
| September 30, 2026 | 257.29M |
| September 29, 2026 | 259.28M |
| September 28, 2026 | 260.61M |
| September 25, 2026 | 258.62M |
| September 24, 2026 | 262.60M |
| September 23, 2026 | 268.56M |
| September 22, 2026 | 274.53M |
| September 21, 2026 | 262.60M |
| September 18, 2026 | 257.95M |
| September 17, 2026 | 246.02M |
| September 16, 2026 | 244.03M |
| September 15, 2026 | 247.34M |
| September 14, 2026 | 254.64M |
| September 11, 2026 | 259.28M |
| September 10, 2026 | 258.62M |
| September 09, 2026 | 268.56M |
| September 08, 2026 | 274.53M |
| September 04, 2026 | 305.70M |
| September 03, 2026 | 288.46M |
| September 02, 2026 | 297.08M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Mirum Pharmaceuticals, Inc. | 6.169B |
| ACADIA Pharmaceuticals, Inc. | 3.174B |
| Alnylam Pharmaceuticals, Inc. | 21.40B |
| Anika Therapeutics, Inc. | 186.85M |
| Savara, Inc. | 1.026B |
Market Cap Related Metrics
| Price | 3.29 |
| Earnings Yield | -13.06% |